DVAI34:BVMF
德维特
R$893.56
0.00%
(0.00) 1 天
10月9日, GMT-3 16:56:00 · BRL
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 DVAI34 生成关键数据洞见…
开盘价
R$893.56
最高价
R$893.56
最低价
R$893.56
市值
115.98亿
平均成交量
7.00
成交量
1.00
52 周最高价
R$1,253.26
52 周最低价
R$546.63
流通股数
6380.00万
员工人数
8万
开盘价
R$893.56
最高价
R$893.56
最低价
R$893.56
市值
115.98亿
平均成交量
7.00
成交量
1.00
52 周最高价
R$1,253.26
52 周最低价
R$546.63
流通股数
6380.00万
员工人数
8万
新闻报道
来自网络来源和新闻合作伙伴
TradingKey
·
21小时前
道指升近200点，费半跌超2%；记忆体股跌幅居前；美光跌逾4%，Meta升超3%
www.tmgm.com
·
6小时前
道琼斯工业平均指数小幅走高，因无存储芯片可供出售
FOREX.com
·
8小时前
油价与美元齐涨 道琼斯指数逆势三连阳
Traders Union
·
1天前
Ryan Detrick指出，S&P 500自2019年以来的涨幅主要由盈利和股息推动
资料
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
德维特简介